Skip to content

Anesthesia Induced Myocardial Injury in Non-cardiac Surgery (AIMY)

Anesthesia Induced Myocardial Injury in Non-cardiac Surgery (AIMY)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07179029
Acronym
AIMY
Enrollment
3000
Registered
2025-09-17
Start date
2025-05-01
Completion date
2028-05-31
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Myocardial Injury

Keywords

troponin, Perioperative myocardial injury

Brief summary

Myocardial injury during non-cardiac surgery (PMI) affects up to 16% of high-risk patients and represents a significant burden on healthcare systems. An acute myocardial infarction is defined by a dynamic increase in cardiac troponin (cTn) above the 99th percentile and is accompanied by clinical signs of myocardial ischemia. Myocardial injury, on the other hand, is characterized by an increase in cardiac troponin, but without meeting the diagnostic criteria for myocardial infarction. In the perioperative interval, however, it is irrelevant whether a myocardial infarction according to the universal definition or merely an increase in troponin is present, as there is no difference in mortality between the two patient groups. The comprehensive study by Botto et al. provides valuable insights into the severity of MINS and found that 8.0% of patients met the diagnostic criteria. An important finding of this study is that the majority of MINS cases (87.1%) occurred within the first two days after surgery, highlighting the immediate risk of the condition (Botto et al., 2014). We would like to emphasize the necessity of our prospective, multicenter observational study by highlighting anesthesia-dependent variables such as hemodynamics, type of medication, their potential role, and surgical aspects such as duration of surgery, which represent risk factors for MINS. Identifying and understanding modifiable and non-modifiable risk factors is essential for targeted preoperative intervention. Understanding these factors is crucial for subsequent interventional studies and can also provide criteria for increased monitoring of high-risk patients, as suggested in the current guidelines.

Interventions

None listed

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elective or emergency non-cardiac surgery * Cardiovascular risk: At least two of the following: Age \>60 years, hypertension, diabetes mellitus, coronary heart disease, peripheral arterial occlusive disease, cerebrovascular disease, chronic renal insufficiency, chronic heart failure, chronic obstructive pulmonary disease, active smoking * Age criteria: Adults aged 40-80 years. * ASA status: ASA classification II-IV. * Written consent after prior explanation

Exclusion criteria

* o Patients unable to give consent: intubated and sedated patients * Types of surgery: cardiac surgery, including coronary artery bypass grafting, heart valve repair or replacement, and heart transplantation; obstetric procedures, including cesarean section; minor surgical procedures that do not require general or regional anesthesia (e.g., minor dermatological or ophthalmological procedures) * Cardiovascular risk: patients without at least two of the following risk factors: age \<40 or \>80, no history of hypertension, diabetes, coronary artery disease, peripheral arterial disease, cerebrovascular disease, chronic renal failure, chronic heart failure, chronic obstructive pulmonary disease, and non-smoker status * Age criteria: Patients under 40 or over 80 years of age * ASA status: ASA classification of I.

Design outcomes

Primary

MeasureTime frameDescription
Troponin1-5 daysDevelopment of Troponin after non-cardiac surgery
incidence of PMI1-5 daysincidence of PMI after non-cardiac surgery

Secondary

MeasureTime frameDescription
Mortality1-30 daysMortality after non-cardiac surgery

Countries

Germany

Contacts

Primary ContactMichael Koeppen, MD
michael.koeppen@med.uni-tuebingen.de+497071-29 86935
Backup ContactSibel Sari-Yavuz, MD
sibel.sari@med.uni-tuebingen.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026